New Zealand markets closed

Johnson & Johnson (JNJ)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
159.38+2.29 (+1.46%)
At close: 04:00PM EST
159.65 +0.27 (+0.17%)
After hours: 07:59PM EST
Full screen
Trade prices are not sourced from all markets
Previous close157.09
Bid0.00 x 800
Ask0.00 x 1300
Day's range157.59 - 159.67
52-week range148.51 - 179.92
Avg. volume7,119,796
Market cap419.584B
Beta (5Y monthly)0.70
PE ratio (TTM)23.82
EPS (TTM)6.69
Earnings date25 Jan 2022
Forward dividend & yield4.24 (2.70%)
Ex-dividend date22 Nov 2021
1y target est187.76
  • Motley Fool

    Why Moderna Is the Biggest Winner From COVID Boosters So Far

    Some Americans could prefer Moderna's booster because of perceptions that it offers higher efficacy.

  • Motley Fool

    2 Robinhood Stocks to Buy and Hold for 10 Years

    Robinhood Markets was one of the pioneers of the commission-free investing model that is now so common among online brokers. At the same time, Robinhood has its share of detractors. Johnson & Johnson (NYSE: JNJ) is one of the largest healthcare companies in the world by market cap, but this juggernaut is about to get smaller.

  • Motley Fool

    Could Bristol Myers Squibb and Johnson & Johnson Have a Powerful New Blood Thinner on the Way?

    Bristol Myers Squibb (NYSE: BMY) and Johnson & Johnson (NYSE: JNJ) compete against each other in the marketplace every day. In this Motley Fool Live video recorded on Nov. 16, 2021, Motley Fool contributors Keith Speights and Brian Orelli discuss the prospects for this experimental drug. Keith Speights: Bristol Myers Squibb and Johnson & Johnson compete head-to-head in the blood thinner market.